Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CAVA vs GSK✓SelectedUSD · GSKCAVA vs GSK performance historyLatest closeAs of-2.88%11/19
Stock and ETF performance explorer

CAVA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-34.4%
GSK return
-3.4%
Excess return
-31.0%
Maximum drawdown
-45.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.9%-1.6%-1.3%-2.6%
7D-10.7%-4.7%-6.0%-9.9%
30D-10.8%-4.7%-6.1%-10.2%
3M-28.4%-8.8%-19.7%-27.1%
6M-34.4%-4.6%-29.8%-33.9%
All-34.4%-3.4%-31.0%-33.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling